Thu, February 22, 2018
Wed, February 21, 2018
Tue, February 20, 2018

Anupam Rama Maintained (SRPT) at Buy with Increased Target to $75 on, Feb 21st, 2018

Anupam Rama of JP Morgan, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Buy with Increased Target from $63 to $75 on, Feb 21st, 2018.

Anupam has made no other calls on SRPT in the last 4 months.



There are 3 other peers that have a rating on SRPT. Out of the 3 peers that are also analyzing SRPT, 1 agrees with Anupam's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Gena Wang of "Barclays" Maintained at Hold with Increased Target to $49 on, Thursday, October 26th, 2017


These are the ratings of the 2 analyists that currently disagree with Anupam


  • Yun Zhong of "Janney Montgomery Scott" Initiated at Strong Buy and Held Target at $75 on, Thursday, January 4th, 2018
  • Debjit Chattopadhyay of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $75 on, Friday, December 1st, 2017